The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer

The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer

Novel magnetic-resonance-guided radiotherapy (MRgRT) permits real-time soft-tissue visualization, respiratory-gated delivery with minimal safety margins, and time-consuming daily plan re-optimisation. We report on early clinical outcomes of MRgRT and routine plan re-optimization for large primary re...

Full description

Bibliographic Details
Main Authors: Shyama U. Tetar, Omar Bohoudi, Suresh Senan, Miguel A. Palacios, Swie S. Oei, Antoinet M. van der Wel, Berend J. Slotman, R. Jeroen A. van Moorselaar, Frank J. Lagerwaard, Anna M. E. Bruynzeel
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
MR-guided
radiotherapy
MRgRT
stereotactic ablative radiotherapy
stereotactic ablative radiation therapy (SABR)
renal cell cancer
Online Access:https://www.mdpi.com/2072-6694/12/10/2763

Internet

https://www.mdpi.com/2072-6694/12/10/2763

Similar Items